Cantargia AB announced the appointment of Monic Stuart, MD, PhD, MBA as Chief Medical Officer, effective immediately. Dr. Stuart will lead the clinical development of nadunolimab across hematological cancers and solid tumors.
Who to call at Cantargia AB, and when
A new leader at Cantargia AB brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Cantargia AB raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cantargia AB, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cantargia AB. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cantargia AB
Location
27 Scheelevaegen
Lund, Skåne County, Sweden
About
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cantargia AB changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LundBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaresearch